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Summary 
Treatment of immature murine B lymphocytes with an antiserum against their surface immuno- 
globulin (slg)M results in cell death via apoptosis. The WEHI 231 B cell line (IgM, kappa) 
has been used extensively as a model for this anti-Ig receptor-mediated apoptosis. Anti-slg treat- 
ment of WEH1231 ceils causes an early, transient increase in the levels of c-myc messenger RNA 
and gene transcription, followed by a rapid decline below control values. Given the evidence 
for a role of the c-myc gene in promoting apoptosis, we have characterized the nature and kinetics 
of changes in the binding of Rd-related factors,  which modulate c-myc promoter activity.  In 
exponentially growing WEHI 231 ceUs, multiple R.el-related binding activities were detectable. 
The major binding species was identified as pS0/c-Rel heterodimers; only minor amounts of 
nuclear factor loB (NF-xB)  (p50/p65) were detectable.  Cotransfection of an inhibitor of NF-KB 
(IxB)-cr expression vector reduced c-rayc-promoter/upstream/exonl-CAT reporter construct ac- 
tivity, indicating the role of Re1 factor binding in c-rayc basal expression in these cells. Treatment 
with anti-slg resulted in a rapid transient increase in the rate of c-ra2/c gene transcription and 
in the binding of Rel factors. At later times, formation of p50 homodimer complexes occurred. 
In cotransfection analysis, p65 and c-Rel expression  potently and modestly transactivated  the 
c-myr promoter, respectively, whereas,  overexpression  of the p50 subunit caused a significant 
drop in its activity. The role of activation of Rel-family binding was demonstrated directly upon 
addition of the antioxidant pyrrolidinedithiocarbamate, which inhibited the anti-slg-mediated 
activation of the endogenous c-myc gene. Similarly, induction after anti-sIg treatment ofa trans- 
fected c-myc promoter was abrogated upon cotransfection of an IxB-o~ expression vector. These 
results implicate the Rel-family in Ig receptor-mediated signals controlling the activation of c-myc 
gene transcription in WEHI 231 cells, and suggest a role for this family in apoptosis of this 
line,  which is mediated through a c-myc signaling pathway. 
N 
'uclear factor KB (NF-KB)  1 elements mediate control of 
a number of important growth regulatory genes (1, 
2). We identified two nuclear factor (NF)-KB dements within 
the murine c-myc oncogene. One site, termed the URE, was 
located 1101-1081 bp upstream of the P1 promoter (3), and 
the second site (IRE) was localized within exon 1 at  +440 
to  +459 bp (4). NF-xB is expressed constitutively in nuclei 
of mature B lymphocytes (5) and can be induced upon differen- 
tiation ofpre-B to B cells (6). In non-B cells, NF-KB activity 
1  Abbreviations used in this  paper: CAT, chloramphenicol acetyl-transferase; 
dm, double mutant; IKB, inhibitor of NF-xB; NF-IcB, nuclear factor KB; 
PDTC, pyrrolidinedithiocarbamate; slg, surface Ig; UP,  E, upstream reg- 
ulatory element. 
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can be induced by a variety of agents, including IL-1, TNF-oz, 
and phorbol ester, as well as upon infection with several  viruses, 
such as HTLV-1 and HIV-1 (1, 2). We demonstrated that ac- 
tivation of NF-KB-Iike factors, upon Ibl treatment of human 
fibroblasts or expression of the tax gene product of the HTLV-1 
virus in T  cells, can induce transcription of the c-myc on- 
cogene (7, 8). 
NF-KB is now known to be a family of dimeric transcrip- 
tion factors with subunits that contain an amino terminal 
stretch of "~300 amino acids that share homology with the 
v-Kel oncogene (9-12).  Classical NF-KB is composed of a 
p50 and a p65 subunit. The p65 subunit contains a more 
potent transactivation domain than the p50 subunit. How- 
ever, it binds less avidly (1, 2, 13-15). Using transient trans- 
fection in NIH 3T3 fibroblasts, we have recently demonstrated 
that expression of p65 alone, or of p65, in combination with 
p50,  potently transactivates  the  murine c-myc promoter, 
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transactivated only weakly (16). In addition, other Rel-related 
subunits have been identified, including RelB and p52 (17-20). 
Treatment of immature IgM-bearing B lymphocytes  with 
an antibody against their expressed surface Ig (slg)M resulted 
in cell death via apoptosis (21). The WEHI 231 lymphoma 
cell line (IgM, kappa) had been characterized as an immature 
B cell on the basis of surface markers and biological proper- 
ties (22,  23).  Treatment of WEHI 231 cells for 18 h with 
an antibody against its  slgM resulted in formation of an 
oligosomal DNA pattern, characteristic  of apoptotic frag- 
mentation of chromatin within nuclei (24,  25). DNA syn- 
thesis ceased within 24-36 h (22, 23, 26). This anti-slg treat- 
ment also resulted in dramatic changes in expression  of the 
c-myc oncogene that preceded DNA degradation. A  5- to 
15-fold increase in c-myc RNA and protein levels between 
the first and second hours was followed by a rapid decline; 
by 8 h of treatment, the levels were well below control values 
(26-28). A major site of control of c-myr expression occurred 
at the level of gene transcription (27).  Several groups have 
now demonstrated that overexpression or inappropriate time 
of expression  of the c-myc gene promotes apoptosis in my- 
eloid, T, and fibroblast cells (29-31).  Using antisense oligo- 
nudeotides, Fischer et al. (32) have recently confirmed a role 
for c-myc expression in induction of apoptosis in the WEHI 
231 line. Given our evidence of the role of Rel-related factors 
in the control of transcription of the c-myc gene, we sought 
to determine the effects of anti-slg treatment on Rel factor 
expression.  Previously, we demonstrated that exponentially 
growing WEHI 231 cells expressed a number of Rel species, 
and that binding was significantly reduced following 24 h 
of anti-Ig treatment (3). Here, we demonstrate that the pre- 
dominant binding activity in WEHI 231 cells is pS0/c-Rel. 
Anti-slg receptor treatment results in an early increase of 
binding, including classical NF-rB p50/p65, that is followed 
by a decrease in overall binding and subsequent appearance 
of p50  homodimers.  Transfection analysis  indicates these 
changes in Rel-related factor binding mediates activation and 
subsequent inhibition of c-myc gene transcription in this B 
cell line. 
Materials and Methods 
Culture and Treatment Conditions.  WEHI 231 cells were main- 
tained in DMEM, supplemented  with 10% FCS (Gibco Laborato- 
ties, Grand Island, NY), 0.35% glucose, 0.058% glutamine, nones- 
sential amino  acids (Gibco), 100  U/ml  penicillin, 100  ~g/ml 
streptomycin, and 50 #M ~-mercaptoethanol, as described previ- 
ously (26). Before antibody treatment, cells  were diluted to a den- 
sity of 3-4  x  10  s ceUs/ml with fresh warm media and allowed 
to incubate for a minimum of 4-5 h. Cell cultures were incubated 
with 5.2/~g/ml anti-~ antibody (Cappel Laboratories, Cochran- 
ville, PA) for 1-18 h. Where indicated, cells were pretreated before 
antibody addition for 1 h with 0.01-2 mM pyrrolidinedithiocarba- 
mate (PDTC) to inhibit NF-rB activation (33). The 70Z/3 pre-B 
lymphoma cells were maintained in RPMI  1640 medium sup- 
plemented with 10% heatqnactivated  FCS and 50 ~M 2-mercapto- 
ethanol. Cells were induced to differentiate with 50 nM PMA 
treatment for 1 h. 
Transfection Analysis.  Exponentially growing WEHI 231 cells 
were washed once with medium and resuspended in DMEM sup- 
plemented with 20% FCS at a concentration of 20  x  106 cells/ml. 
Cells (250 gl)were preincubated on ice for 10 rain with DNA 
(up to 40/zg). Cells were transfected by electroporation at 240 V 
and 960 gF, using a Gene Pulser (Bio-Rad  Laboratories,  Richmond, 
CA). After incubation on ice for 5 min, the cell suspension was 
mixed with 1.75 ml of complete medium and incubated for 10 min 
at room temperature. The suspensions were transferred to petri 
dishes and incubated at 37~  for 24 h. Cells were harvested, and 
the resulting extracts were normalized for total protein content 
by using the Bio-Rad protein quantitation kit. Equal amounts of 
lysates were incubated in duplicate in 2.5 gCi [3H]-acetyl  coen- 
zyme A (New England Nuclear, Boston, MA; 200 mCi/mmol), 
50/~M acetyl  coenzyme  A, and 1.6 mM chloramphenicol  for 1-2 h, 
and the acetylated forms were extracted with ethyl acetate and as- 
sayed by liquid scintillation counting. Standard deviation was ob- 
tained using the Student's t test. The pl.6 Bgl chloramphenicol 
acetyl-transferase  (CAT) construct contains -1141 to +513 bp of 
the mutine c-rayc gene, containing promoter/upstream/exon 1 se- 
quences, including both the URE and IRE (8). The double mu- 
tant pl.6 Bgl construct (dm pl.6 Bgl), prepared by the double  primer 
site-directed mutagenesis method, contains two G to C transver- 
sions in both the URE and IRE elements,  which prevents  Rd factor 
binding and transactivation (8, 16). Vectors  expressing  the pS0 and 
p65 subunits of NF-rB and inhibitor of NF-rB (IrB)-ce and mu- 
fine c-Rel were obtained from U. Siebenlist (National Cancer In- 
stitute [NCI], Bethesda, MD), andJ. Pierce (Brandeis University, 
Waltham, MA), respectively (16, 18). 
Nuclear Run-on Analysis.  Nuclei were isolated from control- 
and antibody-treated  WEH1231 ceils, as described  previously  (27). 
Radiolabeled RNA was analyzed with single stranded DNA of 
the BamHI to HindlII fragment encoding exons 2 and 3 of the 
c-myc  gene (myc) doned into the M13 vector to detect mRNA syn- 
thesis; ~/-2 microglobulin  cDNA, or M13 vector DNA, as described 
previously (27). 
Electrophore~ Mobility Shift Analysis.  Crude nuclear  extracts  were 
prepared by the Strauss and Varshavsky method (34). The frag- 
ment of  DNA spanning Bgl II to Acc I, including base pairs -1139 
to  -921 relative to the Pl promoter of the routine c-myc gene, 
was subloned into pUC 19. This DNA, termed fragment A previ- 
ously (3), includes the NF-rB upstream regulatory element (UP,  E). 
DNA fragments were endlabeled  with the large fragment ofE. coli 
DNA polymerase I (New England Biolabs Inc., Beverly,  MA) and 
[c~-32P]dNTPs (New England Nuclear). The electrophoretic mo- 
bility shift assay  was performed as follows: each 32p-labeled frag- 
ment or double-stranded  oligonucleotide  (25,000 cpm; ~2 ng) and 
5/zg of  nuclear extract were mixed in 70 mM NaCI/10 mM Hepes, 
pH 7.5/1 mM EDTA/lmM dithiothreitol/0.1% Triton X-100/4% 
(vol/vol) glycerol/5/~g of poly(dI-dC)-poly(dI-dC) copolymer, in 
a final  vol of  25 ~1. This mixture was incubated for 30 rain at 22~ 
Competition with cold URE oligonucleotide demonstrated that 
the binding was mediated  by this NF-rB element (3). Alternatively, 
a double stranded oligonucleotide of the rB site from the kappa 
light chain enhancer was used (35). For supershift experiments, 
antibody preparations were added and the mixture incubated as 
indicated in the appropriate legend. Antibody preparations against 
p50 and c-Rel homodimers and 1065 were purchased from Santa 
Cruz; antibodies against p50 and c-Rel were kindly supplied by 
R. Sen (Brandeis University) and N.  Rice (NCI),  respectively. 
Purified IrB-c~ was generously provided by U. Siebenlist (NCI). 
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amide gel with TAE running buffer (6.7 mM Tris-HC1 [pH 7.5], 
3.3 mM sodium acetate,  and 1 mM EDTA), dried, and subjected 
to autoradiography. 
RNA Analysis.  Cytoplasmic RNA was isolated and samples (15 
#g) subjected to Northern blot analysis, as described previously (26). 
R.esul~ 
WEHI 231  Cells Express Multiple  Rel-related Factors.  We 
first sought to characterize the nature of Rel-related factors 
binding  to c-myc  NF-KB elements,  using the URE  NF-KB 
element. Mobility shift analysis was performed with the 221 
bp BgllI-AccI fragment that spans  -1139 to  -921 bp rela- 
tive to the P1 promoter (Fig. 1).  The profiles obtained with 
nuclear extracts from exponentially growing WEHI 231 cells 
are similar to those seen previously (3). Copper phenanthro- 
line footprinting  and competition analysis has  shown  that 
formation of the complexes in bands numbered one to four 
and band six are due to interaction with the URE element 
(3).  When  the profile of complexes obtained with  nuclear 
extracts from WEHI  231 cells was  compared to that from 
70Z/3 pre-B cells induced to differentiate to B cells with LPS 
treatment for 1 h, a complex that comigrated with band three 
was detected (3). Since it has recently been shown that this 
treatment  causes  the  70Z/3  line to  express predominantly 
classical NF-KB (36), we sought to confirm that band three 
represents binding of classical NF-KB. The effects of addition 
of antibodies against  the p65 and p50 subunits  were tested 
(Fig.  1, A  and B).  Addition  of a p65  antibody to binding 
reactions with a WEHI 231 nuclear extract resulted in a selec- 
tive reduction  in formation  of band  three (Fig.  1 A).  For 
the p50 subunit, an antibody preparation that recognizes p50 
subunits in either homodimer or heterodimer complexes was 
employed  (Fig.  1  B).  Addition  of  this  antibody  clearly 
prevented formation of bands  two,  three,  and  four.  Inhibi- 
tion of formation of band one is seen on a darker exposure 
(data not shown). These results indicate that band three, which 
is only a minor complex in WEHI 231 cells, represents binding 
of classical NF-KB, a heterodimer of p50 and p65.  Further- 
more,  most  of the  Rel-related  complexes in  exponentially 
growing WEHI 231 that bind to the NF-KB c-myc element 
contain  a p50  subunit. 
To determine whether any of the complexes contained c-Rel, 
an antibody preparation that reacts with c-Rel was used. Ad- 
dition of this antibody clearly prevented formation of band. 
two,  the major complex observed with  nuclear extracts of 
WEHI 231 cells (Fig.  1 C). Thus, band two appears to rep- 
resent a heterodimer ofp50/c-Rel. This finding is consistent 
with the faster mobility of complexes formed with the URE 
Figure  1.  WEHI  231  cells ex- 
press multiple Pal-related factors. 
Crude nuclear extracts were pre- 
pared by the method of  Strauss and 
Varshavsky (34) from WEHI 231 
cells or from 70Z/3  cells treated 
with  12-O-tetradecanoyl  phorbol- 
13-acetate for 1 h, as described in 
Materials and Methods. The 221 bp 
BgllI  to  AccI DNA  fragment, 
which spans -1139 to -921 bp and 
includes the URE NF-KB  upstream 
regulatory  element,  was end-labeled 
and used  in binding reactions.  Com- 
plexes were resolved  by electropho- 
resis at 11 V/cm in a 4% polyacryl- 
amide gel with TAE running buffer. 
Position of the resolved  bands that 
interact  with the URE element  have 
been numbered 1-6, consistent  with 
the previous  nomenclature (3). (A) 
Effects of an anti-p65 antibody on 
complex  formation. WEH1231 nu- 
clear extract was incubated for 30 
min at room temperature and then 
1 h at 4~  in the presence of 0.5 
#g  anti-p65 antibody, and  the 
resulting complexes  were resolved  as above. (-) Absence  of antibody; (+) presence  of antibody. (B) Effects  of an anti-pS0 antibody preparation. Extracts 
from exponentially  growing WEHI 231 cells  were similarly  incubated  with the normal rabbit serum pre-bleed  (-), or with an antibody that recognizes 
p50 heterodimers (+). (C) Effects  of anti-c-Pal antibody preparations. Extracts from WEHI 231 cells were incubated for 30 rain at room temperature 
and then 16 h at 4~  in the presence of an antibody that recognizes c-Rel protein. (-) Absence of antibody; (+) presence of antibody. (D) Effects 
of an antibody that preferentially  recognizes p50 homodimers (p50H). Nuclear extracts from WEHI 231 cells were incubated for 30 min at room 
temperature and then 1 h at 4~  with 1 #g antibody preparation against p50 homodimers. The dark band that appears in the region between complexes 
five and six appears due to nonspecific  binding of a factor in the antibody preparation to the DNA probe, since it was observed in the absence of 
added extract. (-) Absence of antibody; (+) presence of antibody. 
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c-Kel compared with those expressing pS0/p65  (16). 
Since pS0 appears involved in mediating much of the binding 
to the c-myc elements, an antibody (Santa Cruz) was used 
that has been found to recognize p50 homodimers more effec- 
tively than pS0 in heterodimer complexes (Fig.  1 D). Addi- 
tion  of this  antibody to  a binding  reaction preferentially 
prevented formation of band one. Antibodies against RelB 
and p52 had little consistent effect on complex mobility (data 
not shown). Thus,  the nature of the p50 binding partner 
of band four remains to be determined. In summary, bands 
one, two, and three represent p50 homodimers, and p50/c- 
Rel and pS0/p65  heterodimers, respectively. 
The c-myc Promoter in Exponentially Growing WEHI 231 
Cells Is Transactivated by Rel-related Factor Expression.  Since 
we have demonstrated that Rel-related factors can effectively 
transactivate the c-myc promoter (7, 8, 16), we tested whether 
their expression in WEHI 231 cells mediated transactivation 
of c-myc promoter transcription.  Transfection analysis was 
performed with murine c-myc  promoter/upstream/exonl-CAT 
pl.6 Bgl constructs that contained either wild-type or mu- 
tant versions of the URE and IRE NF-rB elements (8). After 
electroporation into exponentially growing WEHI 231 cells, 
the activity of wild type pl.6 Bgl was found to be mthreefold 
higher than that of the double mutant (dm pl.6 Bgl), sug- 
gesting that part of the promoter activity was due to binding 
of Rel-related factors (Fig.  2).  Since IrB-a has been found 
to bind to both the p65 and c-Rel subunits and prevent trans- 
activation, a cotransfection experiment was performed using 
an IrB-tx expression vector. Cotransfection of a vector ex- 
pressing IrB-a reduced the activity of wild-type pl.6 Bgl, 
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in a dose-dependent fashion, to that of the double mutant 
pl.6 Bgl (Fig.  2). As expected, the activity of dm pl.6 Bgl 
was essentially unaffected by expression of IrB-~. These results 
indicate that Rel-factor binding plays a significant role in tran- 
scription of the c-myc promoter in exponentially growing 
WEHI  231  cells. 
Anti-slg  Treatment Induces Rel-related Factor Binding.  We 
next sought to determine the effects of anti-slg treatment 
on binding of Kel-related factors and to correlate any changes 
with the effects of this treatment on the rate of c-myc gene 
transcription. Nuclei were isolated from WEHI 231 cells in 
exponential growth and,  after 1,  2,  4,  8,  12,  and 18 h  of 
treatment with anti-slg, used in run-on and mobility shift 
analyses (Fig. 3). Transcription of c-myc RNA increased dra- 
matically by 1 h after anti-slg treatment, remained elevated 
at 2 h, and decreased to levels somewhat below those seen 
in exponentially growing cells within 4 h  (Fig.  3 A). Be- 
tween 4 and 8 h, the rate of transcription dropped well below 
control values and remained depressed throughout the re- 
mainder of the time course. 
Treatment with anti-slg for 1 h caused a very significant 
increase in binding to the 221 bp fragment. In particular, 
a transient increase in intensity of formation of complexes 
in the regions between bands two and five was noted (Fig. 
3 B). Specifically, an increase was noted in bands two and 
three; these are better seen in the duplicate experiment shown 
in Fig.  3 C.  By 4 h, the levels of the all of the complexes, 
except for band two, were somewhat below those seen in 
extracts from control cells. Between 8 and 12 h of treatment, 
an increase in formation of band one was seen. To estimate 
the extent of the increase in binding after I h of anti-slg treat- 
ment, mobility shift analysis was performed with an oligo- 
nucleotide containing a single NF-rB element, under very 
low resolving conditions, to yield a single band; an approxi- 
mate twofold increase in binding was observed (data not 
shown). Thus, an increase in overall binding of Kel-related 
factors parallels  the early increase in the rate of c-myc gene 
transcription after anti-slg treatment, while the decrease in 
the rate of transcription is paralleled by an initial drop in overall 
binding and a later increase in appearance of p50 homodimers. 
Expression of  p65 and c-Rel Activates the c-myc Promoter Tran- 
sc@tion. To test whether activation of Kel-related factors upon 
anti-slg treatment can significantly enhance transcription of 
the c-myc promoter, cotransfection analysis was performed 
using the pl.6 Bgl constructs and vectors expressing either 
the p65 or murine c-Rel subunits. Increasing amounts of p65 
expression vector stimulated activity of wild-type pl.6 Bgl 
up to sixfold, while higher doses displayed somewhat reduced 
activation (Fig. 4), as seen previously in NIH 3T3 cells (16). 
3  4  The mutant pl.6 Bgl was unaffected by p65 expression, indi- 
IkB  cating that the activation is due to binding to the NF-rB 
elements, as expected. Expression of murine c-Rel was able 
to modestly induce activity of the c-myc promoter;  an in- 
crease of 1.8-fold  was noted with wild-type pl.6 Bgl (Fig. 
5). These results are similar to those seen upon cotransfec- 
tion into NIH 3T3 cells, which express only minimal consti- 
tutive binding levels of Rel-related factors.  Thus activation 
of Rel-related factors upon anti-slg treatment can significantly 
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Figure 2.  Mutation  of the NF-r.B sites and expression  of IrB-c~  inhibits 
c-myc  promoter  activity.  Exponentially  growing  WEH1231 cells  were  elec- 
troporated in duplicate  with 30 #g pl.6 Bgl (filled bars), or with dm pl.6 
Bgl (open bars), in the absence (bars 1  ) or presence  of 1, 5, 10 #g of an 
boB-or  expression  vector  (bars  2-4, respectively),  and enough  pUC19 DNA 
to make up a final total amount of 40/zg DNA. Extracts were assayed 
for CAT activity and the data presented relative to the pl.6 Bgl alone. 
1172 Figure  3.  Anti-lg treatment of WEHI 231 cells tran- 
siently activates c-myc  gene transcription and Rel-related 
binding.  (A) Nuclear run-on  analysis. Nuclei were iso- 
lated from WEHI 231 cells at the indicated time points 
and the radiolabeled  RNA products analyzed  with single- 
stranded DNA of the BamHI to HindlII fragment en- 
coding exons two and three of the c-myc  gene (my) cloned 
into  the  M13  vector to detect  mRNA  synthesis; ~-2 
microglobulin  cDNA and M13 vector  DNA. A slight over- 
loading of the label was apparent at the 12 h time point. 
(B) Mobility shift analysis. Extracts were prepared from 
WEHI 231 cell nuclei, isolated above in A, and used in 
mobility shift analysis as described in the legend to Fig. 
1. (C) Mobility shift analysis of the early effects of anti- 
slg treatment. Nuclear  extracts  were prepared  from WEHI 
231 cells isolated at the indicated time points and equal 
amounts of protein used in mobility shift analysis, as de- 
scribed above. 
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Figure  4.  Expression  of p65 potently enhances c-myc  promoter activity. 
Exponentially growing WEHI 231 cells were electroporated in duplicate 
with 10/~g pl.6 Bgl (filled bars) or dm pl.6 Bgl (open bars) in the absence 
(bars 1 ) or presence of increasing levels of a p65 expression vector (bars 
2-5 contained 1, 5, 10, and 20/~g, respectively)  and enough pUC19 DNA 
to make a final amount of 40/~g DNA. Extracts were assayed for CAT 
activity, as above in Fig. 3. The data are presented relative to the value 
obtained in the absence of p65 expression vector for both the wild-type 
and dm pl.6 Bgl constructs. 
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enhance transcription  of the c-myc  promoter in WEHI  231 
cells. 
Expression  of-p50 Represses c-myc Promoter  Transc@tion in 
WEHI 231  Cells. Expression of the p50 subunit  of NF-KB, 
which can bind effectively as a homodimer to many NF-KB 
elements, including  the URE (16), has been found to trans- 
activate in vivo only rarely (16).  To determine whether  ex- 
pression of p50 is able to affect the activity of the c-myc pro- 
moter in WEHI  231 cells,  a cotransfection experiment was 
performed (Fig. 6). Expression ofpS0 caused a dose-dependent 
decrease in activity of the pl.6 Bgl, in contrast to the results 
we obtained in  NIH 3T3 cells where it had little effect on 
the activity of pl.6 Bgl (16). This result suggests that over- 
expression  of pS0 in WEHI  231  cells,  which  can compete 
for binding  of more active Rel-related factors, decreases the 
activity of the c-myc  promoter.  This  suggests  that  the  ap- 
pearance of p50 homodimers between 8 and  12 h  after anti- 
slg  treatment  can  negatively  affect c-myc  expression. 
Inhibition of  Rel-related Factor  Activation Prevents Induction of 
c-myc RNA  Levels.  Schreck,  Baeuerle,  and coworkers (33) 
have shown  that  the antioxidant  PDTC  selectively inhibits 
activation  of Rel-related  factors.  To  measure  the  effects of 
PDTC addition,  WEHI  231 cells were incubated for 1 h  in 
media containing increasing concentrations of PD'IC, ranging 
from 0.01-1.0  mM,  and  then  treated  for  1 h  with  anti-Ig. 
Mobility shift analysis indicated that pretreatment with PDTC 
prevented  Rel-related  factor induction  in  a  dose-dependent c- 
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Figure 5.  Expression of c-lLel enhances c-rayc promoter activity. Ex- 
ponentially growing WEHI 231 cells  were electroporated in duplicate with 
10/~g pl.6 Bgl (filled bars) or dm pl.6 Bgl (open bars) in the absence (bars 
I ) or presence of 5, 10, and 20/~g (bars 2-4,  respectively) of a murine 
c-Rd expression vector. The data are presented as above in Fig. 4. 
fashion (data not shown) similar to reports by Schreck et al. 
(33).  Therefore, a concentration of 0.2 mM was chosen. To 
test the effects of PDTC on induction of c-myc mRNA levels 
after anti-Ig treatment, cytoplasmic RNA was isolated from 
WEHI 231 cells in exponential growth, or I h after anti-Ig 
treatment, in the absence or presence of preincubation with 
0.2 mM PDTC for 1 h  (anti-Ig:  -  or 1+1h PDTC, respec- 
tively). As seen in the resulting Northern blot (Fig. 7), anti- 
Ig treatment of WEHI 231 caused a significant increase in 
c-myc mRNA levels, as we have reported previously (26, 27). 
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Figure 6.  Expression of p50 inhibits  c-myc  promoter activity. Exponen- 
tially growing WEHI 231 cells were electroporated in duplicate with 30 
/~g pl.6 Bgl (filled bars) or dm pl.6 Bgl (open bars) in the absence (bars 
l ) or presence of 1, 5, and 10/zg (bars 2-4, respectively) of a p50 expres- 
sion vector, and analyzed as above in Fig. 2. 
Figure 7.  The antioxidant PDTC 
blocks activation of Rel-binding  and 
induction  of c-rnyr  mRNA levels  after 
anti-lg  treatment. Cytoplasmic RNA 
was isolated from cells in exponential 
growth (E) or cells pre-treated with 
0.2 mM PDTC for 1 h and then in- 
cubated in the presence of anti-lg  for 
an additional 1 h (anti-Ig,  1+ lh) or 
left in the absence of additional treat- 
ment (control,  1+1h).  Samples (15 
/~g) were subjected to Northern blot 
analysis,  using  the  murine  c-rayc 
eDNA clone pM-c-myc54  (44) or his- 
tone H3.2 probe  (37). 
Preincubation with PDTC inhibited the transient induction 
of c-myc mRNA levels. To confirm the specificity of the effects 
on c-myc  expression and to evaluate the early effects of  PDTC 
on cell growth, the Northern blot was probed for histone 
H3.2 mRNA, an S-phased expressed RNA (37). No changes 
in expression of this mRNA resulted from the PDTC treat- 
ment. Furthermore, there were no significant differences in 
the major proteins produced when these cytoplasmic RNA 
preparations were used to prime a rabbit reticulocyte  cell-free 
system (data not shown). Thus PDTC, a selective inhibitor 
of Rel-related factor activation, blocks the increase in c-myc 
gene expression in WEHI 231 cells induced by anti-slg treat- 
ment, which is consistent with the transfection analysis. 
Mutation or IKB Expression Prevents Activation of the c-myc 
Promoter after Anti-slg  Treatment.  As an additional test of 
the role of Rel-factor activation in  the induction of c-myc 
gene transcription, we tested the effects of mutation and of 
cotransfection of the IKB-ol vector on the ability of anti-slg 
treatment to activate pl.6 Bgl.  WEHI 231  cells were ana- 
lyzed 6 h after anti-slg treatment to allow for protein trans- 
lation of induced CAT RNA  (Fig.  8).  As seen above,  the 
activity of the wild-type pl.6 Bgl was higher than that of 
dm pl.6 Bgl. A 2.5-fold induction was seen with the wild- 
type pl.6 Bgl construct. In contrast, anti-slg treatment failed 
to induce the double mutant. Furthermore, coexpression of 
IxB-c~ blocked the activation of pl.6 Bgl mediated by anti- 
slg, but had essentially no effect on dm pl.6 Bgl. These results 
indicate that the induction of Rel-related factors after anti- 
slg treatment plays a role in the activation of c-myc promoter 
transcription in WEHI  231  cells. 
Discussion 
Here we have demonstrated that the routine B cell lym- 
phoma line WEHI 231 (IgM, kappa) expresses multiple nu- 
clear tLel-related complexes that bind to the NF-t~B elements 
and regulate transactivation of the c-myc gene. Furthermore, 
the changes in expression of this family of factors after anti- 
slg treatment plays a role in the transient increase and subse- 
quent decrease in c-myc gene transcription, which precedes 
apoptosis  of these cells. In exponentially growing WEH1231 
cells, the predominant nuclear complex binding to the c-myc 
URE NF-KB element was p50/c-Rel heterodimer, and the 
1174  Rel-factors Mediate Control of c-myc Expression During B Cell Apoptosis 3. 
t- 
.O  2. 
t- 
-o 
O  1. 
￿9  1.6 Bgl myc-CAT 
1"3  dm1.6 Bgl myc-CAT 
none  GaMIg  GaMIg + IkB 
Figure  8.  Mutation of the NF-KB dements or expression of IKB-~ in- 
hibits  the anti-slg-mediated induction of c-rayc promoter transcription. 
WEHI 231 cells were electroporated  in duplicate  with 10 #g p1.6 Bgl 
(filled bar) or dm p1.6 Bgl (open bar) in the absence (bars I and 2) or pres- 
ence of 10/~g IKB-tx expression vector (bars 3 ) in the presence of enough 
pUC19 DNA to make a final amount of 40 #g DNA, After 20 min at 
room temperature,  cells in bars 2 and 3 were treated with anti-# H chain, 
and extracts  were prepared  after 6 h and assayed as above in Fig.  2. 
level of classical NF-KB binding was very low. Comigrating 
complexes of similar relative intensities were seen with the 
DNA fragment containing the second c-myc NF-KB element, 
the IRE (data not shown; reference 4). The binding of these 
Rel-related factors appeared to functionally transactivate c-myc 
expression,  since expression of the inhibitor protein I~B-oe 
reduced the activity of a transfected c-myc promoter signifi- 
cantly, as did site-directed mutations in the two NF-KB ele- 
ments. Treatment of WEHI 231 cells with anti-slg resulted 
in a transient increase in binding of c-Rel factors that was 
followed by a decline in binding and a subsequent appear- 
ance of pS0 homodimers. Cotransfection analysis indicated 
that the early activation of p65 and c-Rel-containing com- 
plexes would result in a transient peak in c-myc expression, 
while induction of p50 would inhibit transcription of this 
gene. This was further indicated by pretreatment of WEHI 
231 cells with the antioxidant PDTC, which prevented induc- 
tion of Rel-factor binding and blocked the increase in c-myc 
mRNA levels that normally follow anti-slg treatment, and 
by the ability of mutations in the URE and IRE sites and 
of expression of I~cB-c~ to prevent the anti-slg-mediated ac- 
tivation ofc-myc promoter transcription. Taken together, these 
findings indicate that Rel family expression  contributes to 
the constitutive level of c-myc gene expression in WEHI 231 
B cells, as well as to the changes in expression of this gene 
induced by anti-slg treatment of this line. 
Since WEHI 231 cells express the K light chain gene, we 
were surprised to determine that the predominant species was 
pS0/c-Rel.  Similar  results have recently been reported by 
Verma, Baltimore, Rice and their co-workers (36, 38, 39). 
These workers have presented evidence that Rel-family ex- 
pression proceeds in two stages during pre-B cell B cell de- 
velopment. They have shown that in pre-B cells induced to 
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differentiation to B cells  (e.g.,  70Z/3 line),  activation of 
pS0/p65 occurs (36, 38). Whereas in early B cells, pS0/c-Rel 
was predominant. Thus, a switch that is presumably develop- 
mentally regulated has apparently occurred. Thus, our finding 
that p50/c-Kel is the predominant complex binding to the 
c-myc URE in WEHI  231 is consistent with these other 
reports. Furthermore, binding of p50/p65 to the URE in 
exponentially growing WEHI 231 cells was very minimal. 
Our ability to detect this complex probably reflects the in- 
nate ability  of the UKE sequence to bind classical NF-KB, 
as shown by Rosen and co-workers (40). Anti-slg treatment 
resulted in a significant induction of Rel-factor binding that 
activates transcription of the c-myc gene. While induction 
of c-myc  does not lead to proliferation of the WEH1231 cells, 
a similar induction of Kel binding has been reported previ- 
ously in normal splenic B lymphocytes after treatment with 
anti-Ig (35). In this case, the B cells are induced to proliferate. 
The work presented here suggests that  anti-Ig receptor- 
mediated activation of Rel-factor binding may play a role in 
induction of proliferation of normal B lymphocytes. 
The changes in binding of Rel-related factors also appears 
to play a role in the decrease in the rate of c-myc gene tran- 
scription. To date, the Rel-family has not been associated with 
direct negative effects on transcription in mammalian cells. 
The initial drop in c-myc gene transcription can be related 
in part to a loss of binding. Between 8 and 12 h, a significant 
increase in binding of pS0 homodimers (band 1) was noted. 
This increase could be due to a selective decline in expression 
of the other subunits (e.g.,  c-Rel and p65) or a decrease in 
expression of the inhibitor protein Bcl-3, which has been found 
to selectively complex with p50 subunits and prevents their 
binding to DNA (41). We have found that homodimers of 
p50 fail to transactivate the c-myc promoter in NIH 3T3 cells, 
which express only low levels of Rel-related factors (16). Thus, 
in WEHI 231 cells, the observed inhibition by overexpres- 
sion of p50 is most likely due to competition for binding 
of active factors,  such as classical NF-KB with p50, which 
lacks a transactivation domain. 
The c-myc gene has been implicated in programmed cell 
death. Overexpression of c-my accelerates apoptosis after IL-3 
deprivation of the 32D IL-3-dependent myeloid cell line and 
upon growth arrest, either by serum deprivation, isoleucine 
deprivation, or thymidine block of 3T3 fibroblasts (29, 31). 
Addition  of  an  antisense  c-myc oligonucleotide inhibits 
receptor-mediated apoptosis in immature T  cells and some 
T  cell hybridomas (30,  42).  More recently,  the anti-slg- 
induced apoptosis of WEHI 231 cells has been shown to be 
similarly blocked by addition of an antisense c-myc oligonu- 
cleotide, although the disappearance of the c-myc protein was 
not apparent (reference 32, our unpublished observations). 
Our results suggest a possible role for NF-~B-like factor ex- 
pression in the receptor-mediated activation of the pathway 
leading to programmed cell death in WEHI 231 B cells. In- 
terestingly, high levels of c-Rel expression have been associated 
with programmed cell death in the developing avian embryo 
and in bone marrow cells in vitro (43). Experiments are in 
progress to test the role of Rel-family expression in induc- 
tion of apoptosis in B cell models of tolerance. We thank Drs. R. Bravo,  J. Pierce, N. Rice, R. Sen, and U. Sieblenblist for generously providing antibody 
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